Ginkgo Bioworks plans to go public by merging with special purpose acquisition company (SPAC), Soaring Eagle Acquisition Corp. But there’s no word yet on its anticipated release date or projected share price. Here's how investors in Canada can prepare to buy in when Ginkgo Bioworks finally goes public.

Ginkgo Bioworks (DNA) stock summary

Company stock name	Ginkgo Bioworks Holdings
Stock ticker symbol	DNA
Exchange	NYSE
Open	$8.91
High	$9.61
Low	$8.91
Close	$9.29
Adjusted closing	$9.29
Volume The number of stocks traded during the day	750,464
52-week stock price range	$5.00 – $17.58
Where to buy Ginkgo Bioworks stock	Buy on Qtrade

The values in this table are accurate as of the market close on February 12, 2026, and all amounts are in USD.

Can I buy Ginkgo Bioworks stock in Canada?

Yes, you can buy Ginkgo Bioworks stock in Canada. You simply need to open a brokerage account with an online trading platform that supports stocks on the NYSE exchange. Platforms like Interactive Brokers will allow you to directly buy Ginkgo Bioworks stock from within Canada.

Dive deeper: Detailed guide on how to buy stocks in Canada

Our top picks for where to buy Ginkgo Bioworks stock

Ginkgo Bioworks stock chart (NYSE: DNA)

This chart tracks Ginkgo Bioworks stock price performance over time.

Ginkgo Bioworks stock price

Ginkgo Bioworks's stock price at the last available market close was $9.29 (as of February 12, 2026). For comparison, seven days ago Ginkgo Bioworks's stock price was $10.10. A full 30 days ago it was $9.58, and a year ago it was $14.73.

Is Ginkgo Bioworks stock a buy or sell right now?

The technical analysis gauge above shows real-time buy or sell ratings and analysis for Ginkgo Bioworks stock based on your selected timeframe. It uses three widely followed indicators—moving averages, oscillators and pivots—but this does not represent investment advice or a guarantee of success. Finder may not concur with these signals and accepts no responsibility for the performance of your stocks.

Can I buy Ginkgo Bioworks stock on the TSX?

No, you cannot buy Ginkgo Bioworks stock on the TSX because Ginkgo Bioworks stock is not listed on the TSX. Instead, Ginkgo Bioworks stock is listed on the NYSE under the symbol "DNA."

That said, if you're wondering how to invest in Ginkgo Bioworks stock in Canada, you still have the option to do so by opening a trading account with a Canadian brokerage that gives you access to NYSE, like Interactive Brokers.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Ginkgo Bioworks stock dividends

Ginkgo Bioworks is not expected to pay a dividend over the next 12 months. We'll continue to monitor Ginkgo Bioworks's stock information and update this guide if that changes.

Ginkgo Bioworks stock performance metrics

Here are some common key metrics for Ginkgo Bioworks stock that analysts often use to help gauge a stock's value—P/E ratio, PEG ratio and EBITDA.

• Ginkgo Bioworks's P/E ratio

  Ginkgo Bioworks's current share price divided by its per-share earnings (EPS) over the past 12 months gives a trailing price/earnings (P/E) ratio of roughly 0x. In other words, Ginkgo Bioworks shares trade at around 0 times recent earnings.

  That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stock or simply that they're over-valued.

• Ginkgo Bioworks's PEG ratio

  Ginkgo Bioworks's price/earnings-to-growth (PEG) ratio is calculated by dividing its P/E ratio by its earnings growth, which comes out to about None. A lower ratio can suggest a stock offers better value, while a higher ratio may suggest worse value.

  The PEG ratio provides a broader view than the P/E ratio alone, as it factors in Ginkgo Bioworks's expected earnings growth. By accounting for growth, investors can use the PEG ratio to compare the valuations of multiple high-growth companies.

Has Ginkgo Bioworks stock ever split?

Ginkgo Bioworks's stocks were split on a 1:40 basis on August 19, 2024. So, if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ginkgo Bioworks stocks, just the quantity.

However, indirectly, the new 3900% higher stock price could have impacted the market appetite for Ginkgo Bioworks stocks, which in turn could have impacted Ginkgo Bioworks's stock price.

How volatile is Ginkgo Bioworks stock?

Over the last 12 months, Ginkgo Bioworks's stocks price has ranged from $5.00 to as high as $17.58. Ginkgo Bioworks's beta measurement of stock volatility is 1.56. For comparison, the market () average beta is 1. This would suggest that Ginkgo Bioworks's stocks are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Some analysists use "beta" to gauge a stock's volatility. Beta is a popular way to measure a stocks volatility in relation to the market. Here is a breakdown of Ginkgo Bioworks's beta stock volatility rating.

Ginkgo Bioworks Holdings company and revenue performance

Market Capitalization The total market value of Ginkgo Bioworks's outstanding shares	$612 million
Gross profit (TTM)	$131.3 million
Profit margin	-188.00%
Revenue (TTM)	$180.6 million
Return on assets (TTM)	-15.55%
Return on equity (TTM)	-50.02%
Earnings per share (TTM)	-$6.18
50-day moving stock price average The average share price over the last 50 days	$9.07
200-day moving stock price average The average share price over the last 200 days	$10.31

All dollar amounts in this table are in USD. TTM refers to the "trailing 12 months." All values are accurate as of the market close on February 12, 2026.

Ginkgo Bioworks company profile

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments.

The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats.

The company serves the pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

• Common company-related questions about Ginkgo Bioworks

  What percentage of Ginkgo Bioworks is owned by insiders or institutions?
  Currently 3.469% of Ginkgo Bioworks stocks are held by insiders and 71.544% by institutions.

  How many people work for Ginkgo Bioworks?
  Latest data suggests 834 work at Ginkgo Bioworks.

  When does the fiscal year end for Ginkgo Bioworks?
  Ginkgo Bioworks's fiscal year ends in December.

  Where is Ginkgo Bioworks based?
  Ginkgo Bioworks's address is: 27 Drydock Avenue, Boston, MA, United States, 02210

  What is Ginkgo Bioworks's ISIN number?
  Ginkgo Bioworks's international securities identification number is: US37611X2099

  What is Ginkgo Bioworks's CUSIP number?
  Ginkgo Bioworks's Committee on Uniform Securities Identification Procedures number is: 37611X100

Compare trading platforms to buy Ginkgo Bioworks stock

Compare special offers, low fees and a wide range of investment options among popular trading platforms in Canada. Note that the dollar amounts in the table below are in CAD.

Related: Compare the best stock trading platforms in Canada

Do I have to pay tax on gains from Ginkgo Bioworks stock sales in Canada?

Yes, you'll need to pay taxes in Canada on investment income, which includes any profit from selling Ginkgo Bioworks stock. The CRA taxes investment income from stocks in Canada based on three main factors:

1. Investment income. Investment income includes money earned from interest, dividends or capital gains, which may affect how much you have to pay in taxes on stock sales in Canada.
2. Investor type. Your investment income will be taxed differently depending on whether you're a regular investor or a day trader (which means you buy and trade stocks on a daily basis as your primary form of income).
3. Tax bracket. The higher your tax bracket, the more you'll pay on income from stock sales. Your tax bracket depends on your gross income (minus deductions).

You can learn more about the tax implications of selling stocks in Canada here.

Frequently asked questions about Ginkgo Bioworks stock

• Can I buy Ginkgo Bioworks stock directly as a Canadian investor?

  Yes, Canadian investors can buy Ginkgo Bioworks stock directly through various online brokerage platforms available in Canada. You can compare trading platform options and fees for buying Ginkgo Bioworks stock in our table here.

• How much is Ginkgo Bioworks stock worth?

  As of the last market close (on February 12, 2026), Ginkgo Bioworks stock is worth $9.29 per share.

• Can Canadians buy American stocks?

  Yes, Canadians can buy American stocks through Canadian trading platforms that give access to American stock exchanges such as the NYSE and Nasdaq. The good news is that most Canadian brokerage platforms, like Questrade, Interactive Brokers, Moomoo and Wealthsimple, give access to US exchanges. Read our full guide on how to buy US stocks in Canada to learn more.

• Can I buy fractional shares of Ginkgo Bioworks stock?

  Yes, it may be possible to buy fractional shares of Ginkgo Bioworks stock depending on the trading platform you're signed up with. Fractional shares can allow you to invest in Ginkgo Bioworks stock even when you can't afford its full share price. You can read our full guide to how fractional shares work to learn more.

  The table below shows trading apps in Canada that offer fractional shares:

  3 of 3 results

  Finder Score	Available Asset Types	Account Types	Stock Trading Fee	Monthly Account Fee
  Promoted Finder Score 9.1 Excellent Questrade	Finder Score 9.1 Excellent	Stocks, Bonds, Options, Mutual Funds, Index Funds, ETFs, Forex, GICs, Precious Metals, IPOs	RRSP, RESP, RRIF, TFSA, Personal, Joint, FHSA	$0	$0	Go to site View details Compare product selection Compare	loading
  Finder Rewards Exclusive Finder Score 7.4 Great Moomoo	Finder Score 7.4 Great	Stocks, Options, ETFs	RRSP, TFSA, Personal, FHSA	$1.49/stock	$0	ENDS SOON! $100 DIGITAL VISA CARD REWARD 1 Join Finder 2 Open and fund a Moomoo stock trading account 3 Get a digital Visa gift card from Finder Ends by. T&Cs apply.	Get up to $4,600+ in trading perks T&Cs apply..	Go to site View details Compare product selection Compare	loading
  Finder Score 8.8 Great Interactive Brokers	Finder Score 8.8 Great	Stocks, Bonds, Options, Index Funds, ETFs, Forex, Currencies, Futures	RRSP, TFSA, Personal, Joint, Business, FHSA	Min $1.00, Max 0.5%	$0	View details Compare product selection Compare	loading

  loading

  Load More

  Showing 3 of 3 results

  Finder Score for stock trading platforms

  To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score, the better the platform—it's that simple.

  Read the full methodology

Related: New to stock trading? Compare brokers and get tips for investing.

Important information: Powered by Finder.com. This information is general in nature and is no substitute for professional advice. It does not take into account your personal situation. This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for most investors. You do not own or have any interest in the underlying asset. Capital is at risk, including the risk of losing more than the amount originally put in, market volatility and liquidity risks. Past performance is no guarantee of future results. Tax on profits may apply. Consider the Product Disclosure Statement and Target Market Determination for the product on the provider's website. Consider your own circumstances, including whether you can afford to take the high risk of losing your money and possess the relevant experience and knowledge. We recommend that you obtain independent advice from a suitably licensed financial advisor before making any trades.